Results of Transarterial Embolization for Treating Type 2 Endoleaks: A Single Center Experience.
type 2 endoleaks (T2E) are the main cause of reintervention after endovascular repair of abdominal aortic aneurysms (EVAR). The objective of this study is to quantify success rates of T2E treatment METHODS: retrospective analysis of a prospectively-maintained database containing all consecutive patients treated for a T2E between 2003 and 2017 in a single center. Technical success was defined as absence of endoleak in the final angiographic control after treatment. Clinical success was defined as absence of sac growth over 5 mm in the contrast-enhanced computed tomography performed a year thereafter. Statistics included Kaplan Meier survival estimates. 528 elective EVAR were performed in the period. 36 of these (6.8%) developed a T2E requiring reintervention, a median of 37.9 months after EVAR. A 25.0% of the treatments were performed more than 5 years postintervention. 28 of the 36 treatments were performed via transarterial embolization. For this technique, technical success was of 71.4% and clinical success of 62.5%. A 35.7% of patients required a subsequent reintervention. In this cohort, the rate of aneurysm rupture was 10.7% (n=3/28), open surgical conversion was needed in a 7.1% (n=2/28) and aneurysm-related death was of 14.3% (n=4/28) over follow-up. a high percentage of patients are at risk of adverse outcomes after T2E treatment. Strict imaging follow-up is still needed in this population.